AnalystsEvan SeigermanEvan Seigerman's Stock Forecasts
AnalystsEvan Seigerman
Analyst Ranking
Bottom 8%
#3811 out of 4129 analysts
Average Return
-8.03%
Win Rate
41%17 out of 41
Risk vs Reward
Poor
Good
Evan Seigerman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Eli Lilly & CoLLY | +38.73% | $260.70 | $361.67 | 2021-11-19 - 2022-11-18 | Buy |
Vertex Pharmaceuticals IncVRTX | +36.39% | $228.61 | $311.81 | 2022-01-20 - 2022-12-06 | Buy |
Bristol Myers Squibb CoBMY | +33.93% | $57.83 | $77.45 | 2021-11-19 - 2022-11-18 | Buy |
Regeneron Pharmaceuticals IncREGN | +28.81% | $468.03 | $602.89 | 2021-02-23 - 2022-02-22 | Buy |
Regeneron Pharmaceuticals IncREGN | +27.46% | $376.42 | $479.77 | 2019-12-13 - 2020-12-11 | Buy |
Evan Seigerman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Replimune Group IncREPL | 1 | Buy | $40.00 | +111.75% | Maintains | 2 months ago |
Biogen IncBIIB | 7 | Buy | $360.00 | +23.51% | Upgrades | 2 months ago |
Bristol Myers Squibb CoBMY | 4 | Buy | $94.00 | +17.62% | Maintains | 3 months ago |
Regeneron Pharmaceuticals IncREGN | 9 | Buy | $788.00 | +5.42% | Maintains | 4 months ago |
Nuvation Bio IncNUVB | 2 | Hold | $2.50 | +25.63% | Downgrades | 4 months ago |
Gilead Sciences IncGILD | 7 | Hold | $63.00 | -28.38% | Maintains | 7 months ago |
Eli Lilly & CoLLY | 2 | Buy | $358.00 | -2.86% | Maintains | 7 months ago |
Candel Therapeutics IncCADL | 2 | Buy | $12.00 | +618.56% | Maintains | 8 months ago |
Vertex Pharmaceuticals IncVRTX | 5 | Buy | $274.00 | -12.13% | Upgrades | a year ago |
Mirati Therapeutics IncMRTX | 3 | Buy | $187.00 | N/A | Initiates Coverage On | a year ago |
Pfizer IncPFE | 1 | Buy | $60.00 | N/A | Initiates Coverage On | a year ago |
Incyte CorpINCY | 2 | Hold | $75.00 | N/A | Initiates Coverage On | a year ago |
Amgen IncAMGN | 4 | Hold | $228.00 | N/A | Initiates Coverage On | a year ago |
Neurocrine Biosciences IncNBIX | 3 | Sell | $76.00 | N/A | Initiates Coverage On | a year ago |
Ikena Oncology IncIKNA | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Satsuma Pharmaceuticals IncSTSA | 2 | Hold | $6.50 | N/A | Upgrades | 2 years ago |
Galera Therapeutics IncGRTX | 2 | Buy | $15.00 | N/A | Upgrades | 2 years ago |
Aimmune Therapeutics IncAIMT | 3 | Hold | $34.50 | N/A | Maintains | 2 years ago |
Acelrx Pharmaceuticals IncACRX | 1 | Sell | $0.69 | N/A | Downgrades | 2 years ago |
Macrogenics IncMGNX | 1 | Buy | $13.00 | N/A | Maintains | 3 years ago |
©2022 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.